logo
logo
COO stock ticker logo

The Cooper Companies, Inc.

NASDAQ•COO
CEO: Mr. Albert G. White III
セクター: Healthcare
業種: Medical - Instruments & Supplies
上場日: 1983-01-21
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
連絡先情報
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, 94583, United States
925-460-3600
www.coopercos.com
時価総額
$13.95B
PER (TTM)
35.0
57.7
配当利回り
--
52週高値
$89.83
52週安値
$61.78
52週レンジ
35%
順位35Top 29.9%
4.6
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 4.6 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q1 2026 データ

売上高

$1.02B+0.00%
直近4四半期の推移

EPS

$0.66+0.00%
直近4四半期の推移

フリーCF

$158.70M+0.00%
直近4四半期の推移

2026 Q1 決算ハイライト

主なハイライト

Net Sales Growth Strong Quarterly net sales reached $1,024.1M, marking an 8% increase compared to prior period sales of $964.7M.
Net Income Rises Net income grew to $130.8M from $104.3M, driving diluted EPS to $0.66 from $0.52 previously.
Operating Cash Flow Boost Cash provided by operating activities increased significantly to $260.9M, up from $190.6M in the prior period.
CooperVision Sales Surge CooperVision net sales grew 8% to $695.1M, led by 10% growth in Toric and multifocal products.

リスク要因

UK Tax Dispute Loss Potential Adverse UK FTT payroll tax decision supports HMRC; potential loss estimated up to £71.7M plus interest.
Increased Short-Term Borrowing Total current liabilities rose sharply to $1,595.7M, driven by $620.7M in short-term debt outstanding.
Global Market Uncertainties Macroeconomic instability, international conflicts, and regulatory changes pose risks to future sales and cash flow performance.
Intangible Asset Exposure Management must continually evaluate goodwill and intangible assets for potential impairment risks across operations.

見通し

Debt Maturity Extended Amendment No. 3 extended maturity for $950.0M of 2021 Term Loan debt to February 2031.
Share Repurchase Activity Repurchased $92.5M in common stock during the quarter; $873.9M remains authorized under the program.
Liquidity Position Stable Current cash and expected operating cash flow deemed sufficient to meet needs for at least 12 months.
CooperVision Expansion Focus Focus remains on global penetration of recently introduced silicone hydrogel products, including MiSight lens approvals.

同業比較

売上高 (TTM)

FMS stock ticker logoFMS
$22.15B
+1.5%
UHS stock ticker logoUHS
$17.36B
+9.7%
SNN stock ticker logoSNN
$11.99B
+11.4%

粗利益率 (最新四半期)

NBIX stock ticker logoNBIX
97.8%
-0.5pp
DOCS stock ticker logoDOCS
89.9%
+0.2pp
COO stock ticker logoCOO
67.9%
-10.1pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
ILMN$17.67B20.834.9%38.4%
HOLX$16.79B31.011.0%27.5%
WST$16.64B33.816.7%7.5%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
0.7%
緩やかな成長
4四半期純利益CAGR
14.3%
収益性の着実な向上
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年5月27日
|
EPS:-
|
売上高:-
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし